2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Human cervicovaginal mucus contains an activity that hinders HIV-1 movement

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cervical and vaginal epithelia are primary barriers against human immunodeficiency virus type I (HIV-1) entry during male-to-female transmission. Cervical mucus (CM) is produced by the endocervix and forms a layer locally as well as in the vaginal compartment in the form of cervicovaginal mucus (CVM). To study the potential barrier function of each mucus type during HIV-1 transmission, we quantified HIV-1 mobility in CM and CVM ex vivo using fluorescent microscopy. Virions and 200-nm PEGylated beads were digitally tracked and mean squared displacement was calculated. The mobility of beads increased significantly in CVM compared to CM, consistent with the known decreased mucin concentration of CVM. Unexpectedly, HIV-1 diffusion was significantly hindered in the same CVM samples in which bead diffusion was unhindered. Inhibition of virus transport was envelope-independent. Our results reveal a previously unknown activity in CVM that is capable of impeding HIV-1 mobility to enhance mucosal barrier function.

          Related collections

          Author and article information

          Journal
          101299742
          35518
          Mucosal Immunol
          Mucosal Immunol
          Mucosal immunology
          1933-0219
          1935-3456
          30 November 2012
          19 September 2012
          March 2013
          01 September 2013
          : 6
          : 2
          : 427-434
          Affiliations
          [1 ]Northwestern University, Cell and Molecular Biology Department, Feinberg School of Medicine, Chicago, IL
          [2 ]University of Utah, Department of Bioengineering, Salt Lake City, UT
          [3 ]Northwestern University, Obstetrics and Gynecology, Section in Family Planning and Contraception, Feinberg School of Medicine, Chicago, IL
          [4 ]University of Utah, Department of Pharmaceutics and Pharmaceutical Chemistry, Salt Lake City, UT
          Author notes
          Correspondence: TJ Hope, thope@ 123456northwestern.edu
          Article
          NIHMS414995
          10.1038/mi.2012.87
          3732193
          22990624
          96bbc8fd-1c40-4b6d-a3f6-ea916045d7c3
          History
          Funding
          Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
          Award ID: R21 AI094584 || AI
          Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
          Award ID: P01 AI082971 || AI
          Categories
          Article

          Immunology
          Immunology

          Comments

          Comment on this article